Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction

Journal of the American College of Cardiology

Volumn 41, Issue 1, 2003, Pages 1-7

  Iwakura, Katsuomi ^a   Ito, Hiroshi ^a   Ikushima, Masashi ^a   Kawano, Shigeo ^a   Okamura, Atsushi ^a   Asano, Katsuaki ^a   Kuroda, Tadashi ^a   Tanaka, Koji ^a   Masuyama, Tohru ^a   Hori, Masatsugu ^a   Fujii, Kenshi ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; CARDIOGENIC SHOCK; CONTROLLED STUDY; DEATH; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSKINESIA; ECHOCARDIOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HEART FAILURE; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE REPERFUSION; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD GLUCOSE; CORONARY CIRCULATION; DIABETES COMPLICATIONS; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; FEMALE; HEMODYNAMIC PROCESSES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; STENTS;

EID: 0037221899     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(02)02626-8     Document Type: Article

References (31)

1. Sewdarsen M, Jialal I, Vythilingum S, Govender G, Rajput MC. Stress hyperglycaemia is a predictor of abnormal glucose tolerance in Indian patients with acute myocardial infarction. Diabetes Res 1987; 6:47-9.
2. Oswald GA, Smith CC, Betteridge DJ, Yudkin JS. Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. BMJ 1986;293:917-22.
3. Oswald GA, Yudkin JS. Hyperglycaemia following acute myocardial infarction: The contribution of undiagnosed diabetes. Diabet Med 1987;4:68-70.
4. Bolk J, van der Ploeg T, Cornel JH, Arnold AE, Sepers J, Uman VA. Impaired glucose metabolism predicts mortality after a myocardial infarction. Int J Cardiol 2001;79:207-14.
5. Tansey MJ, Opie LH. Plasma glucose on admission to hospital as a metabolic index of the severity of acute myocardial infarction. Can J Cardiol 1986;2:326-31.
6. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: A systematic overview. Lancet 2000;355:773-8.
7. Malmberg K, Ryden L, Efendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year. J Am Coll Cardiol 1995;26:57-65.
8. Oswald GA, Corcoran S, Yudkin JS. Prevalence and risks of hyperglycaemia and undiagnosed diabetes in patients with acute myocardial infarction. Lancet 1984;1:1264-7.
9. Reffelmann T, Kloner RA. The 'no-reflow' phenomenon: Basic science and clinical correlates. Heart 2002;87:162-8.
10. Rezkalla SH, Kloner RA. No-reflow phenomenon. Circulation 2002;105:656-62.
11. Ito H, Tomooka T, Sakai N, et al. Lack of myocardial perfusion immediately after successful thrombolysis: A predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 1992;85:1699-705.
12. Porter TR, Li S, Osier R, Deligonul U. The clinical implications of no reflow demonstrated with intravenous perfluorocarbon containing microbubbles following restoration of Thrombolysis In Myocardial Infarction (TIMI) 3 flow in patients with acute myocardial infarction. Am J Cardiol 1998;82:1173-7.
13. Villanueva FS, Glasheen WP, Sklenar J, Kaul S. Characterization of spatial patterns of flow within the reperfused myocardium by myocardial contrast echocardiography: Implications in determining extent of myocardial salvage. Circulation 1993;88:2596-606.
14. Ito H, Maruyama A, lwakura K, et al. Clinical implications of 'no-reflow' phenomenon: A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996;93:223-8.
15. Ito H, Taniyama Y, Iwakura K, et al. Intravenous nicorandil can preserve microvascuiar integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. J Am Coll Cardiol 1999;33:654-60.
16. Rentrop KP, Cohen M, Blanke H, Phillips RA. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985;5:587-92.
17. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989;2:358-67.
18. Ragosta M, Camarano G, Kaul S, et al. Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction: New insights using myocardial contrast echocardiography. Circulation 1994;89:2562-9.
19. Nakagawa Y, Ito H, Kitakaze M, et al. Effect of angina pectoris on myocardial protection in patients with reperfused anterior wall myocardial infarction: Retrospective clinical evidence of 'preconditioning'. J Am Coll Cardiol 1995;25:1076-83.
20. Iwakura K, Ito H, Kawano S, et al. Predictive factors for development of the no-reflow phenomenon in patients with reperfused anterior wall acute myocardial infarction. J Am Coll Cardiol 2001;38:472-7.
21. Marfella R, Esposito K, Giunta R, et al. Circulating adhesion molecules in humans: Role of hyperglycemia and hyperinsulinemia. Circulation 2000;101:2247-51.
22. Booth G, Stalker TJ, Lefer AM, Scalia R. Elevated ambient glucose induces acute inflammatory events in the microvasculature: Effects of insulin. Am J Physiol Endocrinol Metab 2001;280:E848-56.
23. Hokama JY, Ritter LS, Davis-Gorman G, Cimetta AD, Copeland JG, McDonagh PF. Diabetes enhances leukocyte accumulation in the coronary microcirculation early in reperfusion following ischemia. J Diabetes Complications 2000;14:96-107.
24. Engler RL, Dahlgren MD, Morris DD, Peterson MA, Schmid-Schonbein GW. Role of leukocytes in response to acute myocardial ischemia and reflow in dogs. Am J Physiol 1986;251:H314-23.
25. Montalescot G, Barragan P, Wittenberg O, et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 2001;344:1895-903.
26. Shechter M, Merz CN, Paul-Labrador MJ, Kaul S. Blood glucose and platelet-dependent thrombosis in patients with coronary artery disease. J Am Coll Cardiol 2000;35:300-7.
27. Kersten JR, Schmeling TJ, Orth KG, Pagel PS, Waltier DC. Acute hyperglycemia abolishes ischemic preconditioning in vivo. Am J Physiol Heart Circ Physiol 1998;275:H721-5.
28. ATP channels. Am J Physiol Heart Circ Physiol 2001;280:H1744-50.
29. Kersten JR, Toller WG, Tessmer JP, Pagel PS, Waltier DC. Hyperglycemia reduces coronary collateral blood flow through a nitric oxide-mediated mechanism. Am J Physiol Heart Circ Physiol 2001;281:H2097-104.
30. McDonagh PH, Hokama JY, Copeland JG, Reynolds JM. The blood contribution to early myocardial perfusion injury in amplified in diabetes. Diabetes 1997;46:1859-67.
31. Kondo M, Tamura K, Tanio T, Shimono Y. Is ST segment reelevation associated with reperfusion an indicator of marked myocardial damage after thrombolysis? J Am Coll Cardiol 1993;21:62-7.